FibroGen Inc
NASDAQ:FGEN
FibroGen Inc
NASDAQ:FGEN
Price:
7.99
USD
-2.08%
Market Closed
Market Cap:
$32.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
FibroGen Inc
NASDAQ:FGEN
|
US |
|
BCP Investment Corp
NASDAQ:BCIC
|
US |
|
A
|
Azimut Holding SpA
OTC:AZIHF
|
IT |
|
S
|
Sankyo Tateyama Inc
TSE:5932
|
JP |
|
Q
|
QTC Energy PCL
SET:QTC
|
TH |
|
J
|
Jash Engineering Ltd
NSE:JASH
|
IN |
|
Zhicheng Technology Group Ltd
HKEX:8511
|
CN |
|
A
|
Advtech Ltd
JSE:ADH
|
ZA |
|
Suparma Tbk PT
IDX:SPMA
|
ID |
|
J
|
Jolimark Holdings Ltd
HKEX:2028
|
HK |
|
C
|
Chesnara PLC
LSE:CSN
|
UK |
|
G
|
Grupa Azoty Zaklady Azotowe Pulawy SA
WSE:ZAP
|
PL |
|
Westwing Group SE
XETRA:WEW
|
DE |
|
Shanghai Hollywave Electronic System Co Ltd
SSE:688682
|
CN |
|
Hyundai Home Shopping Network Corp
KRX:057050
|
KR |
|
Trustpilot Group PLC
LSE:TRST
|
UK |
|
Toyo Denki Seizo KK
TSE:6505
|
JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
JP |
|
Bonterra Energy Corp
TSX:BNE
|
CA |
|
Sheffield Resources Ltd
ASX:SFX
|
AU |
|
Kingsoft Cloud Holdings Ltd
NASDAQ:KC
|
CN |
|
M
|
Midland Ic&I Ltd
HKEX:459
|
HK |
|
T
|
Tabula Rasa HealthCare Inc
F:43T
|
US |
|
TV18 Broadcast Ltd
NSE:TV18BRDCST
|
IN |
Multiples-Based Value
The Multiples-Based Value of one
FGEN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 7.99 USD,
FibroGen Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
FGEN Multiples-Based Value
LOCKED
Multiples Across Competitors
FGEN Competitors Multiples
FibroGen Inc Competitors
FibroGen Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
FibroGen Inc
NASDAQ:FGEN
|
32.3m USD | 3.9 | 0.1 | 0.5 | 0.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD | 6 | 87.3 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD | 5 | 23.9 | 13.9 | 13.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD | 9.2 | 27.9 | 20.9 | 21.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD | 5.6 | 17.9 | 13.4 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3 | 33.2 | 11.2 | 14 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.1 | 35.8 | 38.9 | 39.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
